Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis

Clinical and Vaccine Immunology

Volumn 18, Issue 1, 2011, Pages 35-42

  Latner, Donald R ^a   McGrew, Marcia ^a   Williams, Nobia ^a   Lowe, Luis ^a   Werman, Roniel ^b   Warnock, Eli ^b   Gallagher, Kathleen ^a   Doyle, Peter ^c   Smole, Sandra ^d   Lett, Susan ^d   Cocoros, Noelle ^d   DeMaria, Alfred ^d   Konomi, Raimond ^d   Brown, Cedric J ^a   Rota, Paul A ^a   Bellini, William J ^a   Hickman, Carole J ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

^d MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; MEASLES MUMPS RUBELLA VACCINE; VIRUS ANTIBODY;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN EXPERIMENT; MEMORY CELL; MUMPS; NORMAL HUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS DETECTION;

ADULT; ANTIBODIES, VIRAL; ANTIBODY-PRODUCING CELLS; B-LYMPHOCYTES; ENZYME-LINKED IMMUNOSPOT ASSAY; HUMANS; IMMUNOLOGIC MEMORY; MEASLES; MEASLES VIRUS; MEASLES-MUMPS-RUBELLA VACCINE; MIDDLE AGED; MUMPS; MUMPS VIRUS; RUBELLA; RUBELLA VIRUS; UNITED STATES; VACCINATION;

EID: 78650921943     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00284-10     Document Type: Article

References (48)

1. Abernathy, E., C. Cabezas, H. Sun, Q. Zheng, M. H. Chen, C. Castillo-Solorzano, A. C. Ortiz, F. Osores, L. Oliveira, A. Whittembury, J. K. Andrus, R. F. Helfand, and J. Icenogle. 2009. Confirmation of rubella within 4 days of rash onset: comparison of rubella virus RNA detection in oral fluid with immunoglobulin M detection in serum or oral fluid. J. Clin. Microbiol. 47:182-188.
2. Anderson, L. J., and J. F. Seward. 2008. Mumps epidemiology and immunity: the anatomy of a modern epidemic. Pediatr. Infect. Dis. J. 27:S75-S79.
3. Arduino, P. G., M. Carrozzo, M. Pentenero, G. Bertolusso, and S. Gandolfo. 2006. Non-neoplastic salivary gland diseases. Minerva Stomatol. 55:249-270.
4. Arvilommi, H. 1996. ELISPOT for detecting antibody-secreting cells in response to infections and vaccination. APMIS 104:401-410. (Pubitemid 26264354)
5. Bitsko, R. H., M. M. Cortese, G. H. Dayan, P. A. Rota, L. Lowe, S. C. Iversen, and W. J. Bellini. 2008. Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage. J. Clin. Microbiol. 46:1101-1103.
6. Boddicker, J. D., P. A. Rota, T. Kreman, A. Wangeman, L. Lowe, K. B. Hummel, R. Thompson, W. J. Bellini, M. Pentella, and L. E. Desjardin. 2007. Real-time reverse transcription-PCR assay for detection of mumps virus RNA in clinical specimens. J. Clin. Microbiol. 45:2902-2908.
7. Box, G. E. P., and D. R. Cox. 1964. An analysis of transformations. J. R. Stat. Soc. Ser. B 26:211-252.
8. Centers for Disease Control and Prevention. 2006. Brief report: update: mumps activity - United States, January 1-October 7, 2006. MMWR Morb. Mortal. Wkly. Rep. 55:1152-1153.
9. Centers for Disease Control and Prevention. 2005. Elimination of rubella and congenital rubella syndrome-United States, 1969-2004. MMWR Morb. Mortal. Wkly. Rep. 54:279-282.
10. Centers for Disease Control and Prevention. 2008. Measles - United States, January 1-April 25, 2008. MMWR Morb. Mortal. Wkly. Rep. 57:494-498.
11. Centers for Disease Control and Prevention. 2010. Notifiable diseases and mortality tables. MMWR Morb. Mortal. Wkly. Rep. 59:1282.
12. Centers for Disease Control and Prevention. 2008. Update: measles - United States, January-July 2008. MMWR Morb. Mortal. Wkly. Rep. 57:893-896.
13. Centers for Disease Control and Prevention. 2006. Update: multistate outbreak of mumps - United States, January 1-May 2, 2006. MMWR Morb. Mortal. Wkly. Rep. 55:559-563.
14. Centers for Disease Control and Prevention. 2010. Update: mumps outbreak - New York and New Jersey, June 2009-January 2010. MMWR Morb. Mortal. Wkly. Rep. 59:125-129.
15. Cooney, M. K., J. P. Fox, and C. E. Hall. 1975. The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae. Am. J. Epidemiol. 101:532-551.
16. Crotty, S., R. D. Aubert, J. Glidewell, and R. Ahmed. 2004. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286:111-122.
17. Crotty, S., P. Felgner, H. Davies, J. Glidewell, L. Villarreal, and R. Ahmed. 2003. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171:4969-4973.
18. Czerkinsky, C. C., L. A. Nilsson, H. Nygren, O. Ouchterlony, and A. Tarkowski. 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65:109-121.
19. Davidkin, I., S. Jokinen, A. Paananen, P. Leinikki, and H. Peltola. 2005. Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella. J. Infect. Dis. 191:719-723.
20. Falk, W. A., K. Buchan, M. Dow, J. Z. Garson, E. Hill, M. Nosal, M. Tarrant, R. C. Westbury, and F. M. White. 1989. The epidemiology of mumps in southern Alberta 1980-1982. Am. J. Epidemiol. 130:736-749.
21. Giglio, M. S., M. Landaeta, and M. E. Pinto. 1997. Microbiology of recurrent parotitis. Pediatr. Infect. Dis. J. 16:386-390.
22. Gut, J. P., C. Lablache, S. Behr, and A. Kirn. 1995. Symptomatic mumps virus reinfections. J. Med. Virol. 45:17-23.
23. Hummel, K. B., D. D. Erdman, J. Heath, and W. J. Bellini. 1992. Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J. Clin. Microbiol. 30:2874-2880.
24. Hummel, K. B., L. Lowe, W. J. Bellini, and P. A. Rota. 2006. Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens. J. Virol. Methods 132:166-173.
25. Jin, L., D. W. Brown, P. A. Litton, and J. M. White. 2004. Genetic diversity of mumps virus in oral fluid specimens: application to mumps epidemiological study. J. Infect. Dis. 189:1001-1008.
26. Jin, L., B. Rima, D. Brown, C. Orvell, T. Tecle, M. Afzal, K. Uchida, T. Nakayama, J. W. Song, C. Kang, P. A. Rota, W. Xu, and D. Featherstone. 2005. Proposal for genetic characterisation of wild-type mumps strains: preliminary standardisation of the nomenclature. Arch. Virol. 150:1903-1909.
27. Katz, S. L., and A. R. Hinman. 2004. Summary and conclusions: measles elimination meeting, 16-17 March 2000. J. Infect. Dis. 189(Suppl. 1):S43-S47.
28. Leerdam, C. M., H. C. Martin, and D. Isaacs. 2005. Recurrent parotitis of childhood. J. Paediatr. Child Health 41:631-634.
29. Marin, M., H. C. Meissner, and J. F. Seward. 2008. Varicella prevention in the United States: a review of successes and challenges. Pediatrics 122:e744-e751.
30. Marin, M., P. Quinlisk, T. Shimabukuro, C. Sawhney, C. Brown, and C. W. Lebaron. 2008. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students - Iowa, 2006. Vaccine 26:3601-3607.
31. Narita, M., Y. Matsuzono, Y. Takekoshi, S. Yamada, O. Itakura, M. Kubota, H. Kikuta, and T. Togashi. 1998. Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G. Clin. Diagn. Lab. Immunol. 5:799-803.
32. Nojd, J., T. Tecle, A. Samuelsson, and C. Orvell. 2001. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine 19:1727-1731.
33. Orenstein, W. A., M. J. Papania, and M. E. Wharton. 2004. Measles elimination in the United States. J. Infect. Dis. 189(Suppl. 1):S1-S3.
34. Peltola, H., P. S. Kulkarni, S. V. Kapre, M. Paunio, S. S. Jadhav, and R. M. Dhere. 2007. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin. Infect. Dis. 45:459-466.
35. Philip, R. N., K. R. Reinhard, and D. B. Lackman. 1959. Observations on a mumps epidemic in a virgin population. Am. J. Hyg. 69:91-111.
36. Reed, D., G. Brown, R. Merrick, J. Sever, and E. Feltz. 1967. A mumps epidemic on St. George Island, Alaska. JAMA 199:113-117.
37. Reid, F., J. Hassan, F. Irwin, A. Waters, W. Hall, and J. Connell. 2008. Epidemiologic and diagnostic evaluation of a recent mumps outbreak using oral fluid samples. J. Clin. Virol. 41:134-137.
38. Rota, J. S., J. C. Turner, M. K. Yost-Daljev, M. Freeman, D. M. Toney, E. Meisel, N. Williams, S. B. Sowers, L. Lowe, P. A. Rota, L. A. Nicolai, L. Peake, and W. J. Bellini. 2009. Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006. J. Med. Virol. 81:1819-1825.
39. Rubin, S., J. Mauldin, K. Chumakov, J. Vanderzanden, R. Iskow, and K. Carbone. 2006. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine 24:2662-2668.
40. Sedgwick, J. D., and P. G. Holt. 1983. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 57:301-309.
41. Slifka, M. K., and R. Ahmed. 1996. Limiting dilution analysis of virus-specific memory B cells by an ELISPOT assay. J. Immunol. Methods 199:37-46.
42. Slifka, M. K., and R. Ahmed. 1996. Long-term antibody production is sustained by antibody-secreting cells in the bone marrow following acute viral infection. Ann. N. Y. Acad. Sci. 797:166-176.
43. Slifka, M. K., and R. Ahmed. 1996. Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity. Trends Microbiol. 4:394-400.
44. Slifka, M. K., M. Matloubian, and R. Ahmed. 1995. Bone marrow is a major site of long-term antibody production after acute viral infection. J. Virol. 69:1895-1902.
45. Tozzi, A. E., L. P. Celentano, M. L. Ciofi degli Atti, and S. Salmaso. 2005. Diagnosis and management of pertussis. CMAJ 172:509-515.
46. Waxman, M. A., F. M. Abrahamian, D. A. Talan, G. J. Moran, and R. Pinner. 2006. Update on emerging infections from the Centers for Disease Control and Prevention. Multistate outbreak of mumps - United States, January 1-May 2, 2006. Ann. Emerg. Med. 48:332-336.
47. Wrammert, J., K. Smith, J. Miller, W. A. Langley, K. Kokko, C. Larsen, N. Y. Zheng, I. Mays, L. Garman, C. Helms, J. James, G. M. Air, J. D. Capra, R. Ahmed, and P. C. Wilson. 2008. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453:667-671.
48. Yoshida, N., M. Fujino, A. Miyata, T. Nagai, M. Kamada, H. Sakiyama, T. Ihara, T. Kumagai, T. Okafuji, and T. Nakayama. 2008. Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification. J. Med. Virol. 80:517-523.